Dr. Anilkumar O. Mehra, MD

Dr. Mehra practices at Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles.

Dr. Mehra's NPI, 1780622175, was assigned on June 4, 2006. Dr. Mehra holds California license A43285.

Dr. Mehra's primary practice is Los Angeles General Medical Center, at 2051 Marengo St, Room C2K100, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 226-2800.

Dr. Mehra's primary practice is Los Angeles General Medical Center in Los Angeles, California, part of County of Los Angeles. Dr. Mehra is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Mehra to 1 more group practice or clinic, named with a free account. Dr. Mehra's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehra practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mehra's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mehra is licensed in California.

CMS data shows 27 Medicare services from Dr. Mehra across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $1,962 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Mehra in 2024. 65% of them have high blood pressure, and 38% have high cholesterol. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehra's median patient age at 57, with 41% women.

In 2022, Dr. Mehra wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $355 in total drug cost. In 2021, CMS named 26 claims across 2 drugs.

Dr. Mehra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 114 general payments to Dr. Mehra from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Boston Scientific Corporation paid the most, $1,224.